## CONSOLIDATION: AVERAGE RISK ALL: 

This therapy is for all patients with Average Risk B-ALL (post-Induction)

Consolidation is 4 weeks (29 days). Start Consolidation on Day 36 (7 days following Day 29 LP) or when peripheral counts recover with ANC ≥ 750/µL and platelets ≥ 75000/µL (whichever occurs later). This Therapy Delivery Map is on one (1) page.

**VinCRIStine (VCR)**
-	Route: IV push over 1 minute
-	Dosage: 1.5 mg/m2/dose
-   Dilute with 10ml of 0.9% NaCl, IV infusion at 60ml/h
-	Used on Day 1 ONLY 
-	Caution: Maximum dose: 2 mg

**Mercaptopurine (MP)**
-	Route: PO
-	Dosage: 75 mg/m2/dose
-	Used on Days 1 to 28
-	Caution: Dose adjust based on TPMT and NUDT15 testing

**Intrathecal Methotrexate (IT MTX)**
-	Route: IT 
-	Dosage: 
    + Age (yrs) 1-1.99, dose 8 mg
    + Age (yrs) 2-2.99, dose 10 mg
    + Age (yrs) 3-8.99, dose 12 mg
    + Age (yrs) ≥9, dose 15 mg
    + Used on Days 1, 8 & 15

Begin next course (Interim Maintenance I) on Day 29 or when blood count parameters are met (whichever occurs later)

